期刊
JOURNAL OF ETHNOPHARMACOLOGY
卷 242, 期 -, 页码 -出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2019.112061
关键词
Sorbus; Aria; alpha-Amylase; alpha-Glucosidase; In vivo anti-hyperglycaemic activity; Multivariate data analysis
资金
- Apotekerfonden of 1991
- Danish Agency for Science, Technology and Innovation
Ethnopharmacological relevance: Berries of Sorbus species have been used to treat type 2 diabetes in many regions in Europe. Aims of the study: To investigate the inhibitory activity of berry extract of Sorbus on the digestive enzymes a amylase and alpha-glucosidase, two important targets for management of blood glucose for type 2 diabetics. Furthermore, to test the anti-hyperglycaemic potential of S. norvegica berry extract in vivo. Materials and methods: 70% acetone berry extracts of 16 Sorbus species were tested in vitro for inhibition of alpha-amylase and alpha-glucosidase. Single berry extracts were analysed by H-1-NMR spectroscopy and principal component analysis to evaluate the chemical profiles of the extracts. The anti-hyperglycaemic effect was evaluated in an oral starch tolerance test in STZ-treated C57BL/6 mice. Results: The lowest IC50 values against alpha-amylase and alpha-glucosidase were obtained with the Sorbus species belonging to the subspecies Aria, which have simple leaves compared to pinnately compound leaves of the other Sorbus species. Species belonging to subspecies Aria grouped together and away from the other Sorbus species in the score plot, indicating a difference in chemistry. Both the carbohydrate- and polyphenol-fraction contributed to the enzyme inhibition. Extract of the most active species, S. norvegica, had anti-hyperglycaemic activity, at a level 36 times lower than clinically used acarbose, corresponding to a needed daily dose of 900 mg extract. Conclusions: Sorbus species of subspecies Aria have the potential to be used for management of type 2 diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据